These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22807239)
1. Phenotypic variability of parkin mutations in single kindred. Koentjoro B; Park JS; Ha AD; Sue CM Mov Disord; 2012 Sep; 27(10):1299-303. PubMed ID: 22807239 [TBL] [Abstract][Full Text] [Related]
2. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Pramstaller PP; Schlossmacher MG; Jacques TS; Scaravilli F; Eskelson C; Pepivani I; Hedrich K; Adel S; Gonzales-McNeal M; Hilker R; Kramer PL; Klein C Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111 [TBL] [Abstract][Full Text] [Related]
3. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil. Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510 [TBL] [Abstract][Full Text] [Related]
4. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation. Tan LC; Tanner CM; Chen R; Chan P; Farrer M; Hardy J; Langston JW Mov Disord; 2003 Jul; 18(7):758-63. PubMed ID: 12815654 [TBL] [Abstract][Full Text] [Related]
5. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease]. Hattori N Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations. Wiley J; Lynch T; Lincoln S; Skipper L; Hulihan M; Gosal D; Bisceglio G; Kachergus J; Hardy J; Farrer MJ Mov Disord; 2004 Jun; 19(6):677-81. PubMed ID: 15197707 [TBL] [Abstract][Full Text] [Related]
7. Lewy bodies and parkinsonism in families with parkin mutations. Farrer M; Chan P; Chen R; Tan L; Lincoln S; Hernandez D; Forno L; Gwinn-Hardy K; Petrucelli L; Hussey J; Singleton A; Tanner C; Hardy J; Langston JW Ann Neurol; 2001 Sep; 50(3):293-300. PubMed ID: 11558785 [TBL] [Abstract][Full Text] [Related]
8. A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Lohmann E; Thobois S; Lesage S; Broussolle E; du Montcel ST; Ribeiro MJ; Remy P; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Brice A; Neurology; 2009 Jan; 72(2):110-6. PubMed ID: 18987353 [TBL] [Abstract][Full Text] [Related]
9. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method. Bilgic B; Bayram A; Arslan AB; Hanagasi H; Dursun B; Gurvit H; Emre M; Lohmann E Parkinsonism Relat Disord; 2012 Jun; 18(5):562-6. PubMed ID: 22445249 [TBL] [Abstract][Full Text] [Related]
10. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Kay DM; Moran D; Moses L; Poorkaj P; Zabetian CP; Nutt J; Factor SA; Yu CE; Montimurro JS; Keefe RG; Schellenberg GD; Payami H Ann Neurol; 2007 Jan; 61(1):47-54. PubMed ID: 17187375 [TBL] [Abstract][Full Text] [Related]
11. parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease. Poorkaj P; Nutt JG; James D; Gancher S; Bird TD; Steinbart E; Schellenberg GD; Payami H Am J Med Genet A; 2004 Aug; 129A(1):44-50. PubMed ID: 15266615 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease. Bardien S; Keyser R; Yako Y; Lombard D; Carr J Parkinsonism Relat Disord; 2009 Feb; 15(2):116-21. PubMed ID: 18514563 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations. van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425 [TBL] [Abstract][Full Text] [Related]
14. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients. Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG; Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018 [TBL] [Abstract][Full Text] [Related]
15. Complex relationship between Parkin mutations and Parkinson disease. West A; Periquet M; Lincoln S; Lücking CB; Nicholl D; Bonifati V; Rawal N; Gasser T; Lohmann E; Deleuze JF; Maraganore D; Levey A; Wood N; Dürr A; Hardy J; Brice A; Farrer M; Am J Med Genet; 2002 Jul; 114(5):584-91. PubMed ID: 12116199 [TBL] [Abstract][Full Text] [Related]
16. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Deng H; Le WD; Hunter CB; Mejia N; Xie WJ; Jankovic J Arch Neurol; 2007 Mar; 64(3):421-4. PubMed ID: 17353387 [TBL] [Abstract][Full Text] [Related]
17. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996 [TBL] [Abstract][Full Text] [Related]
18. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Marder KS; Tang MX; Mejia-Santana H; Rosado L; Louis ED; Comella CL; Colcher A; Siderowf AD; Jennings D; Nance MA; Bressman S; Scott WK; Tanner CM; Mickel SF; Andrews HF; Waters C; Fahn S; Ross BM; Cote LJ; Frucht S; Ford B; Alcalay RN; Rezak M; Novak K; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Neils GD; Verbitsky M; Kisselev S; Caccappolo E; Ottman R; Clark LN Arch Neurol; 2010 Jun; 67(6):731-8. PubMed ID: 20558392 [TBL] [Abstract][Full Text] [Related]
19. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Sun M; Latourelle JC; Wooten GF; Lew MF; Klein C; Shill HA; Golbe LI; Mark MH; Racette BA; Perlmutter JS; Parsian A; Guttman M; Nicholson G; Xu G; Wilk JB; Saint-Hilaire MH; DeStefano AL; Prakash R; Williamson S; Suchowersky O; Labelle N; Growdon JH; Singer C; Watts RL; Goldwurm S; Pezzoli G; Baker KB; Pramstaller PP; Burn DJ; Chinnery PF; Sherman S; Vieregge P; Litvan I; Gillis T; MacDonald ME; Myers RH; Gusella JF Arch Neurol; 2006 Jun; 63(6):826-32. PubMed ID: 16769863 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain. Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]